{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "UCH-L1",
        "Protein_Change": {
          "ref": "L30K",
          "alt": "L32S",
          "position": "Leu-32"
        },
        "variant_string_id": "UCH-L1 L30K"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Define the disease mechanism.",
          "extracted_paper_info": "The mutation in UCH-L1 has been identified in familial Parkinson's disease, leading to the accumulation of ubiquitination and disruption of cellular function.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly states that UCH-L1 mutation is linked to PD, highlighting its role in neuronal dysfunction and disease progression."
        },
        {
          "step_name": "Evaluate applicability of general classes of assay used in the field.",
          "extracted_paper_info": "The study utilized a combination of enzyme activity assays to assess UCH-L1 function.  The assay employed to determine the function of the protein was to measure the effect of the mutation on its ability to inhibit ubiquitination.",
          "judgment": "Yes",
          "reasoning": "The paper describes the assay and how it was applied."
        },
        {
          "step_name": "Evaluate validity of specific instances of assays.",
          "extracted_paper_info": "The assay was performed in a cell culture setting, with controls including wild-type UCH-L1 and a mutant UCH-L1.",
          "judgment": "Yes",
          "reasoning": "The paper demonstrates the use of controls to ensure the proper evaluation of the assay."
        },
        {
          "step_name": "Apply evidence to individual variant interpretation.",
          "extracted_paper_info": "The authors confirmed the observation that the variant mutation alters the protein's ubiquitin binding activity.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly states that substitution of the leucines within this region (L32S/L32A/L34S/L34A/L39S/L39A) reduced the secretion of UCH-L1."
        },
        {
          "step_name": "Apply evidence to individual variant interpretation.",
          "extracted_paper_info": "The paper measured the secretion of UCH-L1 using a fluorescence-based assay.",
          "judgment": "Yes",
          "reasoning": "The paper measures UCH-L1 secretion with a fluorescent assay."
        },
        {
          "step_name": "Apply evidence to individual variant interpretation.",
          "extracted_paper_info": "The paper used data from an experiment that showed the secretion of UCH-L1 increased with mutation",
          "judgment": "Yes",
          "reasoning": "The paper shows an increase in the secretion of UCH-L1 with the mutation"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The mutation in UCH-L1 has a strong pathogenic effect on UCH-L1 secretion, indicating a significant disruption of protein function and contributing to Parkinsonâ€™s disease pathology."
    }
  ]
}